B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.412 NOK 0.86% Market Closed
Market Cap: 55.2m NOK

Operating Margin
Bergenbio ASA

-17 834.2%
Current
-46 382%
Average
-5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17 834.2%
=
Operating Profit
-151.2m
/
Revenue
848k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
NO
Bergenbio ASA
OSE:BGBIO
55.2m NOK
-17 834%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
327.3B USD
30%
US
Amgen Inc
NASDAQ:AMGN
155.6B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
135.1B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.3B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
116.3B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.2B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.4B USD
-5%

Bergenbio ASA
Glance View

Market Cap
55.2m NOK
Industry
Biotechnology

BerGenBio ASA engages in the development of biopharmaceutical product for cancer therapy. The company is headquartered in Bergen, Hordaland. The company went IPO on 2017-04-07. The firm's business portfolio comprises such development stage products as oral axillary lymphoscintigraphy (AXL) kinase inhibitors, small molecule AXL inhibitors, and antibody programs. Its flagship product is BGB324, an orally avaliable small molecule AXL kinase inhibitor. Inhibition of AXL kinase activity addresses an important mechanism in the evolution of cancer cell in terms of its aggressiveness, and focuses on creation of therapeutic options for cancer patients. The firm also performs a range of clinical trials for interested patients, primarily affected with acute myeloid leukemia and non-small cell lung cancer.

BGBIO Intrinsic Value
Not Available
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17 834.2%
=
Operating Profit
-151.2m
/
Revenue
848k
What is the Operating Margin of Bergenbio ASA?

Based on Bergenbio ASA's most recent financial statements, the company has Operating Margin of -17 834.2%.

Back to Top